Johnson Matthey wins 5-year extension of Sarepta supply contract

Johnson Matthey has landed a 5-year extension of a contract with Sarepta Therapeutics to supply starting materials for PMO drug candidates at facilities in West Deptford, New Jersey, and Devens, Massachusetts.

“The British chemical company Johnson Matthey has landed a 5-year extension of a contract with Sarepta Therapeutics to supply starting materials for the drug firm’s phosphorodiamidate morpholino oligomer (PMO) and peptide PMO drug candidates.”doi.org

• 1 source
• doi.orgMatthey re-ups Sarepta supply contractRick MullinSep 14, 2020

Summarized from public sources; check the original articles before acting on it.